Movement disorders 同济大学;帕金森病:短链脂肪酸减少,或因肠-血屏障受损

2022-06-29 Freeman MedSci原创

PD患者的粪便和血浆SCFAs的改变与GBB受损有关,并可能因便秘而加重。

帕金森病(PD)是一种神经退行性疾病,以运动症状为特征,包括运动迟缓、静止性震颤和僵硬。其病理特征是α-synuclein在大脑中的异常聚集。PD患者还经常表现出非运动症状(NMS),包括胃肠道功能障碍,尤其是早期出现的便秘。

图1: 论文封面图

此外,肠道α-synuclein的积累在运动症状出现之前就已经被检测出来。目前的假说认为,PD的病理生理过程可能源于肠道神经系统。PD患者的肠道微生物群与健康人明显不同,并被认为通过肠道-大脑轴在PD的发生和发展中发挥了重要作用。

细菌膳食纤维在肠道内发酵产生的短链脂肪酸(SCFAs)在维持肠道屏障和增加胃肠道蠕动方面起着重要作用。据报道,PD患者的粪便乙酸(AA)、丙酸(PPA)和丁酸(BA)明显减少,而另一项研究显示PD患者的血浆AA浓度更高。这些研究没有发现PD患者的粪便和血浆中SCFAs的同步变化,同时还有肠道-血液屏障(GBB)的渗透性指标。

因此,粪便和血浆中的对比变化的整体方案和原因仍然未知。大约40%-80%的PD患者表现出便秘或结肠转运时间延长,这对PD相关的微生物群组成有深刻的影响。此外,结肠转运时间的延迟导致微生物代谢从碳水化合物发酵转向蛋白质分解,这影响了肠道SCFAs的产生。因此,结肠转运时间对肠道微生物组成和功能的强烈影响强调了在微生物代谢物研究中考虑结肠转运时间这一混杂因素的重要性。

藉此,同济大学的Xiaodong Yang等人,描述了PD患者队列中粪便和血浆SCFAs的同步改变,并通过将便秘作为混杂因素来确定SCFAs与PD的具体关联。

他们分别用液相和气相色谱质谱法测量了33名健康对照组和95名PD患者的粪便和血浆中SCFAs的浓度。PD患者被分为无便秘的PD患者(n = 35)和有便秘的PD患者(n = 60)。通过血浆/粪便中SCFA浓度的比率和粪便中α1-抗胰蛋白酶的浓度来评估肠道-血液屏障(GBB)的渗透性。

图2:论文结果图


PD患者显示出粪便中乙酸、丙酸和丁酸的浓度下降,血浆中乙酸和丙酸的浓度上升。

与无便秘的PD患者相比,有便秘的PD患者的粪便乙酸、异丁烯酸和异戊烯酸的浓度更低,血浆乙酸和丙酸的浓度更高。便秘加剧了PD患者的GBB渗透性。

粪便和血浆中的SCFAs可以区分PD患者和健康对照对象。

除丙酸外,粪便SCFAs与疾病严重程度呈负相关,而血浆乙酸、丙酸和戊酸呈正相关。

该研究的重要意义在于发现了:PD患者的粪便和血浆SCFAs的改变与GBB受损有关,并可能因便秘而加重。


原文出处:
Yang X, Ai P, He X, et al. Parkinson’s Disease Is Associated with Impaired Gut–Blood Barrier for Short‐Chain Fatty Acids. _Movement Disorders_. Published online May 24, 2022:mds.29063. doi:[10.1002/mds.29063](https://doi.org/10.1002/mds.29063).

评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2013916, encodeId=8f162013916fb, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Oct 24 00:52:06 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738139, encodeId=c7f11e38139d6, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbf34357637, createdName=ms2186806800017884, createdTime=Wed Jun 07 14:52:06 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784524, encodeId=084a1e84524de, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Mon Jul 04 18:52:06 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077707, encodeId=47f620e7707a4, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Jun 10 04:52:06 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878549, encodeId=5d5918e854925, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sun May 07 23:52:06 CST 2023, time=2023-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973887, encodeId=7c2e19e388711, content=<a href='/topic/show?id=0bb8389e6bb' target=_blank style='color:#2F92EE;'>#同济大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38976, encryptionId=0bb8389e6bb, topicName=同济大学)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Mon Aug 01 23:52:06 CST 2022, time=2022-08-01, status=1, ipAttribution=)]
    2022-10-24 cmj8wellington

    #Dis#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2013916, encodeId=8f162013916fb, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Oct 24 00:52:06 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738139, encodeId=c7f11e38139d6, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbf34357637, createdName=ms2186806800017884, createdTime=Wed Jun 07 14:52:06 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784524, encodeId=084a1e84524de, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Mon Jul 04 18:52:06 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077707, encodeId=47f620e7707a4, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Jun 10 04:52:06 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878549, encodeId=5d5918e854925, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sun May 07 23:52:06 CST 2023, time=2023-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973887, encodeId=7c2e19e388711, content=<a href='/topic/show?id=0bb8389e6bb' target=_blank style='color:#2F92EE;'>#同济大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38976, encryptionId=0bb8389e6bb, topicName=同济大学)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Mon Aug 01 23:52:06 CST 2022, time=2022-08-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2013916, encodeId=8f162013916fb, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Oct 24 00:52:06 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738139, encodeId=c7f11e38139d6, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbf34357637, createdName=ms2186806800017884, createdTime=Wed Jun 07 14:52:06 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784524, encodeId=084a1e84524de, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Mon Jul 04 18:52:06 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077707, encodeId=47f620e7707a4, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Jun 10 04:52:06 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878549, encodeId=5d5918e854925, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sun May 07 23:52:06 CST 2023, time=2023-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973887, encodeId=7c2e19e388711, content=<a href='/topic/show?id=0bb8389e6bb' target=_blank style='color:#2F92EE;'>#同济大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38976, encryptionId=0bb8389e6bb, topicName=同济大学)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Mon Aug 01 23:52:06 CST 2022, time=2022-08-01, status=1, ipAttribution=)]
    2022-07-04 cmsvly

    #Disord#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2013916, encodeId=8f162013916fb, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Oct 24 00:52:06 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738139, encodeId=c7f11e38139d6, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbf34357637, createdName=ms2186806800017884, createdTime=Wed Jun 07 14:52:06 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784524, encodeId=084a1e84524de, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Mon Jul 04 18:52:06 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077707, encodeId=47f620e7707a4, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Jun 10 04:52:06 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878549, encodeId=5d5918e854925, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sun May 07 23:52:06 CST 2023, time=2023-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973887, encodeId=7c2e19e388711, content=<a href='/topic/show?id=0bb8389e6bb' target=_blank style='color:#2F92EE;'>#同济大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38976, encryptionId=0bb8389e6bb, topicName=同济大学)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Mon Aug 01 23:52:06 CST 2022, time=2022-08-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2013916, encodeId=8f162013916fb, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Oct 24 00:52:06 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738139, encodeId=c7f11e38139d6, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbf34357637, createdName=ms2186806800017884, createdTime=Wed Jun 07 14:52:06 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784524, encodeId=084a1e84524de, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Mon Jul 04 18:52:06 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077707, encodeId=47f620e7707a4, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Jun 10 04:52:06 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878549, encodeId=5d5918e854925, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sun May 07 23:52:06 CST 2023, time=2023-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973887, encodeId=7c2e19e388711, content=<a href='/topic/show?id=0bb8389e6bb' target=_blank style='color:#2F92EE;'>#同济大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38976, encryptionId=0bb8389e6bb, topicName=同济大学)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Mon Aug 01 23:52:06 CST 2022, time=2022-08-01, status=1, ipAttribution=)]
    2023-05-07 anminleiryan

    #ERS#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2013916, encodeId=8f162013916fb, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Oct 24 00:52:06 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738139, encodeId=c7f11e38139d6, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbf34357637, createdName=ms2186806800017884, createdTime=Wed Jun 07 14:52:06 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784524, encodeId=084a1e84524de, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Mon Jul 04 18:52:06 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077707, encodeId=47f620e7707a4, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Jun 10 04:52:06 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878549, encodeId=5d5918e854925, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sun May 07 23:52:06 CST 2023, time=2023-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973887, encodeId=7c2e19e388711, content=<a href='/topic/show?id=0bb8389e6bb' target=_blank style='color:#2F92EE;'>#同济大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38976, encryptionId=0bb8389e6bb, topicName=同济大学)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Mon Aug 01 23:52:06 CST 2022, time=2022-08-01, status=1, ipAttribution=)]

相关资讯

Movement disorder:-帕金森患者,大脑代谢和步态有何关系?

两个新的与步态有关的大脑网络,在静止状态下葡萄糖代谢发生了改变

Movement disorders:帕金森氏征,多巴胺代谢和大脑血流代谢有何关系?

在PD和四次重复的tauopathy中,前额叶灌注与同侧黑质多巴胺能功能有关

Cell:徐浩新/胡美钦/李平/王策等揭示帕金森病发病风险的新机制

该研究开辟了溶酶体 pH 调节的新方向,首次鉴定出溶酶体膜上的氢离子通道:TMEM175 是一种新型的氢离子激活的氢离子通道。

Movement disorders-帕金森病伴肌张力障碍与否,皮层和下丘脑有何改变?

运动皮层和STN场电位的频谱功率在重复肢体运动时有明显的不同。

Movement disorders:帕金森患者,糖尿病可加速其进展

T2DM与帕金森病的疾病进展速度有关,突出了这两种疾病之间的互动。

MOVEMENT DISORDERS:2型糖尿病与帕金森病更快进展有关

T2DM与帕金森病更快的疾病进展有关,它可能是缓解帕金森症状和减缓残疾和痴呆进展的目标。

拓展阅读

BioScience Trends:帕金森病动物模型中的听力损伤可能与耳蜗传出纤维变化有关

帕金森病模型动物的耳蜗,尤其是其传出神经纤维系统,发生了早期且复杂的病理改变。

中医再亮剑!北京团队解密天麻钩藤饮:先救少突胶质细胞,再护神经元,帕金森“髓鞘-突触”双修复时代开启!

该研究首次将血清药物化学、单细胞转录组、网络药理学与类器官模型整合,阐明TGD“重塑神经元-少突胶质细胞互作”的新机制,为中医“祛风止颤”提供现代注解,也为全球PD复合药物研发贡献可复制的技术范式。

Lancet Neurology:硫唑嘌呤治疗早期帕金森病的概念验证试验,阴性主要终点下的性别差异信号与免疫调控启示

AZA-PD研究虽未支持硫唑嘌呤直接作为帕金森病的治疗选择,但它成功完成了概念验证,打开了通过调节外周免疫系统来干预帕金森病进程的研究大门。

2025帕金森病十大科学研究新进展 | 年终大盘点

神经科学论坛小编系统梳理2025年度最具影响力的十大科研进展,展示人类向帕金森病发起总攻的科学图景。

前沿快讯 | 情绪如何“震颤”?认知怎样“绊脚”?

安徽中医药大学王共强团队通过多模态研究,揭示消极情绪可加剧帕金森病、威尔森病患者震颤,认知负荷会恶化威尔森病患者步态,阐明情绪 - 认知 - 运动整合环路机制,为神经疾病精准干预提供新方向。

大脑“老化时钟”可预测帕金森病恶化速度

这种“异质性”为临床精准管理带来了巨大挑战,也使得旨在延缓甚至阻断疾病进程的新药临床试验举步维艰——为了在“平均”人群中检测出药物效果,往往需要招募成百上千的患者,耗时耗力且成功率低。

2025 共识建议:帕金森病认知障碍的诊断、评估和管理

国外神经内科相关专家小组(统称) · 2025-07-24